Japan's Shimadzu To Develop New Mass Spectroscope
This article was originally published in PharmAsia News
Nobel laureate in chemistry and Shimadzu Mass Spectrometry Research Institute Director Koichi Tanaka announced the company will develop a compact protein mass spectroscope. Tanaka also announced that a joint research project with Fred Hutchison Cancer Research Center in the U.S. to find proteins related to cancer's early diagnosis will begin this autumn. In the research, Tanaka will utilize the mass spectroscope and assess its potential towards commercialization. According to Tanaka, the new equipment will be smaller, have a higher sensitivity and be able to analyze proteins larger in mass compared to current spectroscopes. The company is aiming to market the equipment within three to four years. (Click here for more - Japanese language
You may also be interested in...
No device-related warning letters were released by the US FDA the week of 24 November.
Mooted some time ago, the Medicare Part D Drug Rebate Rule and the Medicare Part B Most-Favored-Nation Model have now been finalized by US President Donald Trump. But US off-patent body the Association for Accessible Medicines feels “further action is necessary.”
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.